Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zepbound
Pharma
Lilly, Novo will be pharma sales leaders by 2030, Evaluate says
Fueled by sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030, Evaluate projects.
Kevin Dunleavy
Jun 23, 2025 9:52am
Lilly fills out lineup of Zepbound doses on self-pay website
Jun 16, 2025 11:48am
Novo's Wegovy secures preferred obesity spot on CVS formulary
May 1, 2025 2:39pm
Eli Lilly CEO critiques Trump trade policies, tariffs
May 1, 2025 1:11pm
BMO says Lilly is pulling ahead of Novo in obesity market battle
Apr 17, 2025 4:30pm
Lilly files lawsuit against spa for selling repackaged Zepbound
Apr 7, 2025 5:00am
